1 paper2 findings
Apathy improvement
downin humans1
Global white matter hyperintensity volume is associated with apathy improvement in humans (Interaction β = 0.207, SE = 0.089; FDR-adjusted p = 0.049).
“global: β = 0.207, SE = 0.089, FDR-adjusted p = 0.049).”
Human trialVascular mild cognitive impairment; response to acetylcysteine plus exercise; lower baseline volume associated with greater improvementbrain2400 mg daily acetylcysteine6 months
Brain scan findings linked to symptom relief in memory trial
Journal of Alzheimer's disease : JAD7 Oct 2026
Neuropsychiatric symptom improvement
downin humans1
Global white matter hyperintensity volume is associated with neuropsychiatric symptom improvement in humans (Interaction β = 0.258, SE = 0.080; FDR-adjusted p = 0.007).
“global (β = 0.258, SE = 0.080, FDR-adjusted p = 0.007) WMH volume was associated with greater reductions in NPS over 6 months”
Human trialVascular mild cognitive impairment; response to acetylcysteine plus exercise; lower baseline volume associated with greater improvementbrain2400 mg daily acetylcysteine6 months
Brain scan findings linked to symptom relief in memory trial
Journal of Alzheimer's disease : JAD7 Oct 2026
In a six-month trial of 51 people with vascular mild cognitive impairment, lower volumes of bright brain areas were linked to greater symptom reductions.In a six-month trial of 51 people with vascular mild cognitive impairment, lower volumes of bright brain areas were linked to greater symptom reductions.